University of Milano-Bicocca

Running trials

• Recruiting

  Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

  NCT03934372· Phase 1/2· Incyte Biosciences International Sàrl· Source

• Recruiting

  National Database on Primary Biliary Cholangitis

  NCT05151809· University of Milano Bicocca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• Childhood cancers1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Primary biliary cholangitis1 recruiting

Closed trials

• Withdrawn

  tDCS to Enhance Cognitive Training in Multiple Sclerosis

  NCT04261556· University of Milano Bicocca· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure133 works · 0 trials
• Ovarian cancer41 works · 0 trials
• Acute lymphoblastic leukaemia30 works · 1 trial
• Glioblastoma28 works · 0 trials
• Primary biliary cholangitis25 works · 1 trial
• Myocarditis19 works · 0 trials
• Obstructive sleep apnoea15 works · 0 trials
• High blood pressure12 works · 0 trials
• Hypertrophic cardiomyopathy12 works · 0 trials
• Psoriatic arthritis12 works · 0 trials
• Ventricular tachycardia10 works · 0 trials
• Neuroblastoma9 works · 0 trials
• Sarcoidosis9 works · 0 trials
• Fabry disease8 works · 0 trials
• Down syndrome8 works · 0 trials
• Tourette syndrome8 works · 0 trials
• Pompe disease6 works · 0 trials
• ANCA-associated vasculitis5 works · 0 trials
• Epidermolysis bullosa4 works · 0 trials
• Haemophagocytic lymphohistiocytosis4 works · 0 trials